TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Sell | S | 12.51 | 8,000 | 100,080 | 21,494 | 29.5 K to 21.5 K (-27.12 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 3,926 | 0 | 3,926 | |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 13,090 | 0 | 0 | |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 12.14 | 3,926 | 47,670 | 2,974 | 6.9 K to 3 K (-56.90 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 12.14 | 13,090 | 158,941 | 6,900 | 20 K to 6.9 K (-65.48 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 3,926 | 0 | 19,990 | 16.1 K to 20 K (+24.44 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 13,090 | 0 | 16,064 | 3 K to 16.1 K (+440.15 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | M | 0.00 | 19,040 | 0 | 0 | |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | M | 0.00 | 5,710 | 0 | 5,712 | |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Buy | M | 0.00 | 5,710 | 0 | 24,750 | 19 K to 24.8 K (+29.99 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Buy | M | 0.00 | 19,040 | 0 | 19,040 | 0 to 19 K |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Sell | S | 13.03 | 72,131 | 939,766 | 0 | 72.1 K to 0 (-100.00 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 17,850 | 0 | 0 | |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 5,353 | 0 | 5,355 | |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 12.14 | 8,825 | 107,155 | 45,061 | 53.9 K to 45.1 K (-16.38 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 12.14 | 2,647 | 32,140 | 53,886 | 56.5 K to 53.9 K (-4.68 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 17,850 | 0 | 56,533 | 38.7 K to 56.5 K (+46.14 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 5,353 | 0 | 38,683 | 33.3 K to 38.7 K (+16.06 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | M | 0.00 | 3,926 | 0 | 3,926 | |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | M | 0.00 | 13,090 | 0 | 0 | |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Sell | S | 12.14 | 1,878 | 22,791 | 29,494 | 31.4 K to 29.5 K (-5.99 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Sell | S | 12.14 | 6,262 | 75,994 | 31,372 | 37.6 K to 31.4 K (-16.64 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Buy | M | 0.00 | 3,926 | 0 | 37,634 | 33.7 K to 37.6 K (+11.65 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Buy | M | 0.00 | 13,090 | 0 | 33,708 | 20.6 K to 33.7 K (+63.49 %) |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Kalif Eliyahu Sharon | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 19,888 | 0 | 19,888 | |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Option Exercise | M | 0.00 | 2,470 | 0 | 0 | |
| Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Buy | M | 0.00 | 2,470 | 0 | 222,912 | 220.4 K to 222.9 K (+1.12 %) |
| Feb 13 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | A | 0.00 | 13,090 | 0 | 13,090 | |
| Feb 13 2020 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Option Exercise | A | 0.00 | 212,314 | 0 | 212,314 | |
| Feb 13 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | A | 0.00 | 19,040 | 0 | 19,040 | |
| Feb 13 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 0.00 | 17,850 | 0 | 17,850 | |
| Feb 13 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | A | 0.00 | 13,090 | 0 | 13,090 | |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 12,538 | 0 | 25,076 | |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 12.24 | 12,538 | 153,471 | 2,974 | 15.5 K to 3 K (-80.83 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 12,538 | 0 | 15,512 | 3 K to 15.5 K (+421.59 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Option Exercise | M | 0.00 | 26,867 | 0 | 53,734 | |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Buy | M | 0.00 | 26,867 | 0 | 90,480 | 63.6 K to 90.5 K (+42.24 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | M | 0.00 | 15,523 | 0 | 31,046 | |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Buy | M | 0.00 | 15,523 | 0 | 72,131 | 56.6 K to 72.1 K (+27.42 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | M | 0.00 | 16,120 | 0 | 32,241 | |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Sell | S | 12.27 | 4,799 | 58,884 | 13,456 | 18.3 K to 13.5 K (-26.29 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Buy | M | 0.00 | 16,120 | 0 | 18,255 | 2.1 K to 18.3 K (+755.04 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Option Exercise | M | 0.00 | 11,941 | 0 | 23,882 | |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Sell | S | 12.24 | 4,155 | 50,864 | 18,464 | 22.6 K to 18.5 K (-18.37 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Buy | M | 0.00 | 11,941 | 0 | 22,619 | 10.7 K to 22.6 K (+111.83 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 16,120 | 0 | 32,241 | |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 12.27 | 5,544 | 68,025 | 33,330 | 38.9 K to 33.3 K (-14.26 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 16,120 | 0 | 38,874 | 22.8 K to 38.9 K (+70.84 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | M | 0.00 | 6,567 | 0 | 13,135 | |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Sell | S | 12.24 | 3,144 | 38,488 | 20,618 | 23.8 K to 20.6 K (-13.23 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Buy | M | 0.00 | 6,567 | 0 | 23,762 | 17.2 K to 23.8 K (+38.19 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 13,135 | 0 | 26,270 | |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Sell | S | 12.27 | 5,669 | 69,559 | 18,061 | 23.7 K to 18.1 K (-23.89 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 13,135 | 0 | 23,730 | 10.6 K to 23.7 K (+123.97 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 13,135 | 0 | 26,270 | |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 12.24 | 6,199 | 75,886 | 8,612 | 14.8 K to 8.6 K (-41.85 %) |
| Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 13,135 | 0 | 14,811 | 1.7 K to 14.8 K (+783.71 %) |